Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
Condition: Asthma Interventions: Drug: Placebo; Drug: Umeclidinium; Drug: Fluticasone Furoate; Drug: Albuterol/salbutamol Sponsor: GlaxoSmithKline Not yet recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials